Ekström J, Månsson B, Tobin G
Acta Physiol Scand. 1983;119(2):169-75. doi: 10.1111/j.1748-1716.1983.tb07322.x.
Vasoactive intestinal peptide (VIP) injected intravenously was found to induce a flow of saliva from both the parotid and the submaxillary gland in the rat. The secretion was slow in onset. The amount of saliva secreted from the parotid gland was less than that from the submaxillary gland. Parotid saliva was very viscous. VIP-evoked parotid saliva was more protein rich than both submaxillary saliva and saliva secreted in response to other sialagogue drugs including the beta-adrenergic receptor agonist isoprenaline. The effect of VIP was direct; it occurred after removal of the adrenals, after degeneration of intraglandular nerves and in the presence of autonomic blockers. A supersensitivity to VIP was demonstrable. In the parotid and the submaxillary glands the secretory response to VIP was enlarged following parasympathetic denervation and decentralization, respectively, while after sympathetic denervation supersensitivity was only found to develop in the submaxillary gland.
静脉注射血管活性肠肽(VIP)可使大鼠腮腺和颌下腺分泌唾液。唾液分泌起效缓慢。腮腺分泌的唾液量少于颌下腺。腮腺唾液非常黏稠。VIP诱发的腮腺唾液比颌下腺唾液以及对包括β-肾上腺素能受体激动剂异丙肾上腺素在内的其他催涎药物产生反应时分泌的唾液富含更多蛋白质。VIP的作用是直接的;在摘除肾上腺后、腺内神经变性后以及存在自主神经阻滞剂的情况下仍会发生。对VIP的超敏反应是可证实的。在腮腺和颌下腺中,分别在副交感神经去神经支配和中枢神经离断后,对VIP的分泌反应增强,而在交感神经去神经支配后,仅在颌下腺发现有超敏反应产生。